Aceto Corporation Stock Price, News & Analysis (NASDAQ:ACET)

$10.08 -0.05 (-0.49 %)
(As of 11/20/2017 10:21 AM ET)
Previous Close$10.13
Today's Range$9.85 - $10.14
52-Week Range$8.29 - $22.46
Volume307,100 shs
Average Volume315,121 shs
Market Capitalization$303.5 million
P/E Ratio8.4
Dividend Yield2.57%
Beta1.38

About Aceto Corporation (NASDAQ:ACET)

Aceto Corporation logoAceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products.


Industry, Sector and Symbol:
  • Industry: Pharmaceuticals
  • Sub-Industry: Trading Companies & Distributors
  • Sector: Medical
  • Symbol: NASDAQ:ACET
  • CUSIP: 00444610
  • Web: www.aceto.com
Debt:
  • Debt-to-Equity Ratio: 0.77%
  • Current Ratio: 2.06%
  • Quick Ratio: 1.46%
Price-To-Earnings:
  • Trailing P/E Ratio: 8.4
  • Forward P/E Ratio: 9.42
  • P/E Growth: 0.94
Sales & Book Value:
  • Annual Sales: $638.32 million
  • Price / Sales: 0.48
  • Cash Flow: $2.43 per share
  • Price / Cash: 4.14
  • Book Value: $13.54 per share
  • Price / Book: 0.74
Dividend:
  • Annual Dividend: $0.26
  • Dividend Yield: 2.6%
Profitability:
  • Trailing EPS: $0.21
  • Net Income: $11.37 million
  • Net Margins: 1.07%
  • Return on Equity: 10.18%
  • Return on Assets: 3.95%
Misc:
  • Employees: 286
  • Outstanding Shares: 30,110,000
 

Frequently Asked Questions for Aceto Corporation (NASDAQ:ACET)

What is Aceto Corporation's stock symbol?

Aceto Corporation trades on the NASDAQ under the ticker symbol "ACET."

How often does Aceto Corporation pay dividends? What is the dividend yield for Aceto Corporation?

Aceto Corporation announced a quarterly dividend on Thursday, August 24th. Shareholders of record on Friday, September 8th will be given a dividend of $0.065 per share on Thursday, September 21st. This represents a $0.26 dividend on an annualized basis and a yield of 2.58%. The ex-dividend date of this dividend is Thursday, September 7th. View Aceto Corporation's Dividend History.

How were Aceto Corporation's earnings last quarter?

Aceto Corporation (NASDAQ:ACET) announced its quarterly earnings data on Thursday, November, 2nd. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.28 by $0.02. The business had revenue of $185.26 million for the quarter, compared to analyst estimates of $190.58 million. Aceto Corporation had a return on equity of 10.18% and a net margin of 1.07%. The business's revenue for the quarter was up 44.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.28 EPS. View Aceto Corporation's Earnings History.

When will Aceto Corporation make its next earnings announcement?

Aceto Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, January, 31st 2018. View Earnings Estimates for Aceto Corporation.

What guidance has Aceto Corporation issued on next quarter's earnings?

Aceto Corporation updated its FY18 earnings guidance on Thursday, November, 2nd. The company provided earnings per share guidance of $1.05-1.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.28. The company issued revenue guidance of $734.07-765.98 million (+15-20%), compared to the consensus revenue estimate of $778.29 million.

Where is Aceto Corporation's stock going? Where will Aceto Corporation's stock price be in 2017?

3 brokerages have issued 12-month price objectives for Aceto Corporation's shares. Their predictions range from $15.00 to $15.00. On average, they anticipate Aceto Corporation's stock price to reach $15.00 in the next twelve months. View Analyst Ratings for Aceto Corporation.

Who are some of Aceto Corporation's key competitors?

Who are Aceto Corporation's key executives?

Aceto Corporation's management team includes the folowing people:

  • Albert L. Eilender, Chairman of the Board (Age 73)
  • William C. Kennally III, President, Chief Executive Officer, Director (Age 61)
  • Douglas A. Roth, Chief Financial Officer, Senior Vice President (Age 59)
  • Walter J. Kaczmarek III, Chief Operating Officer (Age 57)
  • Charles J. Alaimo, Senior Vice President - Human Resources (Age 50)
  • Steven Rogers, Senior Vice President, Chief Legal Officer and Secretary (Age 55)
  • Raymond Bartone, Senior Vice President - Nutritionals (Age 54)
  • Frank V. DeBenedittis, Senior Vice President - Corporate Business Development (Age 61)
  • Terry Kippley, Senior Vice President - Agricultural Protection Products (Age 52)
  • Carlos Restrepo, Senior Vice President - Performance Chemicals (Age 54)

Who owns Aceto Corporation stock?

Aceto Corporation's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (8.10%), Royce & Associates LP (3.11%), Deprince Race & Zollo Inc. (2.46%), Hillcrest Asset Management LLC (1.50%), Citadel Advisors LLC (1.03%) and Ameriprise Financial Inc. (0.97%). Company insiders that own Aceto Corporation stock include Albert L Eilender, Charles John Alaimo, Daniel B Yarosh, Douglas A Roth, Frank Debenedittis, Hans C Noetzli, Nicolas I Shackley, Raymond Bartone, Salvatore J Sr Guccione Sr, Satish Srinivasan, Steven Rogers, Terry Kippley, Walter J Kaczmarek III and William N Britton. View Institutional Ownership Trends for Aceto Corporation.

Who sold Aceto Corporation stock? Who is selling Aceto Corporation stock?

Aceto Corporation's stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Deprince Race & Zollo Inc., King Luther Capital Management Corp, Ameriprise Financial Inc., Dimensional Fund Advisors LP and Hillcrest Asset Management LLC. Company insiders that have sold Aceto Corporation company stock in the last year include Albert L Eilender, Charles John Alaimo, Daniel B Yarosh, Douglas A Roth, Frank Debenedittis, Nicolas I Shackley, Raymond Bartone, Salvatore J Sr Guccione Sr, Satish Srinivasan, Steven Rogers and Walter J Kaczmarek III. View Insider Buying and Selling for Aceto Corporation.

Who bought Aceto Corporation stock? Who is buying Aceto Corporation stock?

Aceto Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Royce & Associates LP, Municipal Employees Retirement System of Michigan, Janney Montgomery Scott LLC, Citadel Advisors LLC, Engineers Gate Manager LP, Dynamic Technology Lab Private Ltd, Systematic Financial Management LP and OxFORD Asset Management LLP. View Insider Buying and Selling for Aceto Corporation.

How do I buy Aceto Corporation stock?

Shares of Aceto Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aceto Corporation's stock price today?

One share of Aceto Corporation stock can currently be purchased for approximately $10.08.

How big of a company is Aceto Corporation?

Aceto Corporation has a market capitalization of $303.5 million and generates $638.32 million in revenue each year. The company earns $11.37 million in net income (profit) each year or $0.21 on an earnings per share basis. Aceto Corporation employs 286 workers across the globe.

How can I contact Aceto Corporation?

Aceto Corporation's mailing address is 4 TRI HARBOR COURT, PORT WASHINGTON NY, 11050. The company can be reached via phone at 516-627-6000 or via email at [email protected]


MarketBeat Community Rating for Aceto Corporation (NASDAQ ACET)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  79 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  185
MarketBeat's community ratings are surveys of what our community members think about Aceto Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Aceto Corporation (NASDAQ:ACET)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 2 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $15.00 (48.81% upside)

Consensus Price Target History for Aceto Corporation (NASDAQ:ACET)

Price Target History for Aceto Corporation (NASDAQ:ACET)

Analysts' Ratings History for Aceto Corporation (NASDAQ:ACET)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/6/2017Canaccord GenuityReiterated RatingBuyN/AView Rating Details
2/3/2017Craig HallumDowngradeBuy -> HoldN/AView Rating Details
1/31/2017First AnalysisDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 11/20/2015 forward)

Earnings

Earnings History and Estimates Chart for Aceto Corporation (NASDAQ:ACET)

Earnings by Quarter for Aceto Corporation (NASDAQ:ACET)

Earnings History by Quarter for Aceto Corporation (NASDAQ ACET)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/31/2018N/AView Earnings Details
11/2/2017Q1 2018$0.28$0.30$190.58 million$185.26 millionViewN/AView Earnings Details
8/24/2017Q4 2017$0.44$0.27$184.49 million$194.60 millionViewN/AView Earnings Details
5/4/2017Q3 2017$0.44$0.39$195.09 million$190.10 millionViewListenView Earnings Details
2/2/2017Q2 2017$0.32$0.24$136.65 million$125.60 millionViewListenView Earnings Details
11/2/2016Q1 17$0.29$0.28$132.88 million$128.02 millionViewListenView Earnings Details
8/25/2016Q416$0.39$0.35$146.71 million$135.40 millionViewListenView Earnings Details
5/5/2016Q3$0.39$0.42$150.07 million$157.90 millionViewListenView Earnings Details
2/4/2016Q2$0.30$0.36$132.71 million$131.70 millionViewListenView Earnings Details
11/5/2015Q116$0.34$0.37$139.89 million$133.50 millionViewListenView Earnings Details
9/10/2015Q415$0.31$0.48$146.68 million$146.60 millionViewListenView Earnings Details
5/7/2015Q3$0.29$0.34$140.00 million$145.80 millionViewListenView Earnings Details
2/5/2015Q115$0.26$0.28$130.00 million$13.00 millionViewListenView Earnings Details
11/6/2014Q414$0.29$0.23$146.40 million$130.80 millionViewListenView Earnings Details
9/4/2014Q314$0.17$0.21$134.23 million$139.60 millionViewListenView Earnings Details
5/8/2014Q214$0.28$0.19$136.70 million$124.83 millionViewListenView Earnings Details
2/7/2014Q114$0.24$0.24$147.02 million$116.50 millionViewListenView Earnings Details
8/28/2013Q4 2013$0.20$0.19$113.10 million$123.10 millionViewListenView Earnings Details
5/9/2013Q3 2013$0.26$0.34$128.56 million$150.90 millionViewListenView Earnings Details
11/8/2012Q113$0.19$0.18$110.85 million$111.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aceto Corporation (NASDAQ:ACET)
2017 EPS Consensus Estimate: $1.53
2018 EPS Consensus Estimate: $1.13
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.29$0.29$0.29
Q2 20172$0.27$0.42$0.35
Q3 20172$0.39$0.47$0.43
Q4 20172$0.43$0.50$0.47
Q1 20182$0.23$0.32$0.28
Q2 20182$0.22$0.29$0.26
Q3 20182$0.25$0.34$0.30
Q4 20182$0.29$0.31$0.30
Q1 20191$0.31$0.31$0.31
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Aceto Corporation (NASDAQ:ACET)

Most Recent Dividend:9/21/2017
Annual Dividend:$0.26
Dividend Yield:2.58%
Payout Ratio:123.82% (Trailing 12 Months of Earnings)
24.30% (Based on This Year's Estimates)
21.14% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Aceto Corporation (NASDAQ:ACET)

Dividend History by Quarter for Aceto Corporation (NASDAQ ACET)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/24/2017quarterly$0.072.29%9/7/20179/8/20179/21/2017
5/4/2017quarterly$0.071.82%6/7/20176/9/20176/23/2017
2/2/2017quarterly$0.071.66%3/8/20173/10/20173/24/2017
12/1/2016quarterly$0.071.3%12/8/201612/12/201612/22/2016
8/25/2016quarterly$0.071.29%9/7/20169/9/20169/20/2016
5/5/2016quarterly$0.061.04%6/7/20166/9/20166/24/2016
2/4/2016quarterly$0.061.18%3/9/20163/11/20163/25/2016
12/3/2015quarterly$0.060.88%12/15/201512/17/201512/28/2015
9/10/2015quarterly$0.060.9%9/17/20159/21/201510/2/2015
5/7/2015quarterly$0.061.12%6/9/20156/11/20156/25/2015
2/5/2015quarterly$0.061.13%3/10/20153/12/20153/26/2015
12/4/2014quarterly$0.061.09%12/11/201412/15/201412/29/2014
9/4/2014quarterly$0.061.12%9/11/20149/15/20149/29/2014
5/8/2014quarterly$0.061.26%6/10/20146/12/20146/27/2014
2/6/2014quarterly$0.061.35%3/11/20143/13/20143/28/2014
12/5/2013quarterly$0.061.08%12/12/201312/16/201312/27/2013
8/28/2013quarterly$0.061.56%9/12/20139/16/20139/27/2013
5/9/2013quarterly$0.062%6/12/20136/14/20136/25/2013
2/7/2013quarterly$0.062.16%3/13/20133/15/20133/26/2013
12/9/2012quarterly$0.062.26%12/13/201212/17/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Aceto Corporation (NASDAQ ACET)

Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 78.81%
Insider Trades by Quarter for Aceto Corporation (NASDAQ:ACET)
Insider Trades by Quarter for Aceto Corporation (NASDAQ:ACET)

Insider Trades by Quarter for Aceto Corporation (NASDAQ ACET)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/8/2017Steven RogersSVPSell2,000$10.34$20,680.00View SEC Filing  
9/7/2017Salvatore J Sr Guccione SrInsiderSell218$10.48$2,284.64View SEC Filing  
9/6/2017Albert L EilenderChairmanSell9,530$10.47$99,779.10View SEC Filing  
9/6/2017Salvatore J Sr Guccione SrInsiderSell9,850$10.47$103,129.50View SEC Filing  
9/6/2017Steven RogersSVPSell2,050$10.47$21,463.50View SEC Filing  
9/5/2017Walter J Kaczmarek IIICOOSell2,635$10.57$27,851.95View SEC Filing  
8/2/2017Walter J Kaczmarek IIICOOSell7,083$16.57$117,365.31View SEC Filing  
7/6/2017Albert L EilenderChairmanSell6,500$15.21$98,865.00View SEC Filing  
7/6/2017Frank DebenedittisInsiderSell2,089$15.28$31,919.92View SEC Filing  
7/6/2017Salvatore J Sr Guccione SrCEOSell7,421$15.21$112,873.41View SEC Filing  
7/5/2017Charles John AlaimoInsiderSell2,612$15.48$40,433.76View SEC Filing  
7/5/2017Douglas A RothCFOSell5,075$15.47$78,510.25View SEC Filing  
7/5/2017Steven RogersSVPSell2,285$15.45$35,303.25View SEC Filing  
3/9/2017Frank DebenedittisInsiderSell3,600$14.94$53,784.00View SEC Filing  
1/17/2017Daniel B YaroshDirectorSell891$20.69$18,434.79View SEC Filing  
12/9/2016Raymond BartoneInsiderSell5,000$21.54$107,700.00View SEC Filing  
12/8/2016Nicolas I ShackleyInsiderSell2,500$21.27$53,175.00View SEC Filing  
11/30/2016Frank DebenedittisInsiderSell7,040$20.22$142,348.80View SEC Filing  
11/29/2016Satish SrinivasanCOOSell12,917$20.02$258,598.34View SEC Filing  
11/28/2016Albert L EilenderChairmanSell18,500$19.88$367,780.00View SEC Filing  
11/23/2016Steven RogersSVPSell2,400$19.53$46,872.00View SEC Filing  
11/14/2016Hans C NoetzliDirectorSell6,000$18.32$109,920.00View SEC Filing  
9/8/2016Salvatore J Sr Guccione SrInsiderSell260$19.64$5,106.40View SEC Filing  
9/7/2016Charles John AlaimoInsiderSell25$19.43$485.75View SEC Filing  
9/6/2016Albert L EilenderChairmanSell12,936$19.92$257,685.12View SEC Filing  
9/6/2016Frank DebenedittisInsiderSell4,580$19.85$90,913.00View SEC Filing  
9/6/2016Satish SrinivasanCOOSell3,980$19.84$78,963.20View SEC Filing  
9/6/2016Steven RogersSVPSell2,167$20.04$43,426.68View SEC Filing  
9/2/2016Charles John AlaimoInsiderSell2,567$19.85$50,954.95View SEC Filing  
7/19/2016Satish SrinivasanCOOSell595$25.48$15,160.60View SEC Filing  
7/7/2016Frank DebenedittisVPSell3,275$23.34$76,438.50View SEC Filing  
7/6/2016Albert L EilenderChairmanSell7,690$22.53$173,255.70View SEC Filing  
7/6/2016Charles John AlaimoSVPSell3,639$22.41$81,549.99View SEC Filing  
7/6/2016Douglas A RothCFOSell6,770$22.72$153,814.40View SEC Filing  
7/6/2016Salvatore J Sr Guccione SrCEOSell10,945$23.25$254,471.25View SEC Filing  
7/6/2016Satish SrinivasanCOOSell3,250$22.80$74,100.00View SEC Filing  
7/6/2016Steven RogersVPSell3,275$22.50$73,687.50View SEC Filing  
6/7/2016Terry KippleyVPSell2,000$22.50$45,000.00View SEC Filing  
6/7/2016William N BrittonDirectorSell4,200$23.12$97,104.00View SEC Filing  
6/6/2016Frank DebenedittisVPSell6,810$22.63$154,110.30View SEC Filing  
6/6/2016Satish SrinivasanCOOSell3,497$22.69$79,346.93View SEC Filing  
5/31/2016Albert L EilenderChairmanSell9,881$22.21$219,457.01View SEC Filing  
5/26/2016Douglas A RothCFOSell7,000$22.16$155,120.00View SEC Filing  
3/10/2016Raymond BartoneSVPSell3,000$22.40$67,200.00View SEC Filing  
3/8/2016Hans C NoetzliDirectorSell6,500$22.91$148,915.00View SEC Filing  
3/2/2016Frank DebenedittisVPSell3,000$21.98$65,940.00View SEC Filing  
3/1/2016Steven RogersVPSell2,100$21.82$45,822.00View SEC Filing  
2/25/2016Albert L EilenderChairmanSell9,281$21.79$202,232.99View SEC Filing  
2/23/2016Charles John AlaimoSVPSell4,750$21.91$104,072.50View SEC Filing  
2/23/2016Douglas A RothCFOSell17,000$21.52$365,840.00View SEC Filing  
12/9/2015Satish SrinivasanCOOSell3,000$27.02$81,060.00View SEC Filing  
12/9/2015Terry KippleyVPSell1,550$27.06$41,943.00View SEC Filing  
12/8/2015Nicolas I ShackleySVPSell3,000$26.70$80,100.00View SEC Filing  
12/1/2015Charles John AlaimoSVPSell3,000$28.22$84,660.00View SEC Filing  
11/25/2015Hans C. NoetzliDirectorSell3,000$27.52$82,560.00View SEC Filing  
11/24/2015Steven RogersVPSell3,000$27.56$82,680.00View SEC Filing  
10/15/2015Albert L. EilenderChairmanSell8,155$28.90$235,679.50View SEC Filing  
9/10/2015Charles John AlaimoSVPSell1,620$22.14$35,866.80View SEC Filing  
9/10/2015Douglas A. RothCFOSell6,250$22.14$138,375.00View SEC Filing  
9/10/2015Frank DebenedittisVPSell2,553$22.14$56,523.42View SEC Filing  
9/10/2015Salvatore J. Sr Guccione, Sr.CEOSell9,386$22.14$207,806.04View SEC Filing  
7/2/2015Albert L EilenderChairmanSell10,938$24.20$264,699.60View SEC Filing  
7/2/2015Charles John AlaimoSVPSell2,998$24.19$72,521.62View SEC Filing  
7/2/2015Douglas A RothCFOSell5,748$24.19$139,044.12View SEC Filing  
7/2/2015Frank DebenedittisVPSell2,629$24.19$63,595.51View SEC Filing  
7/2/2015Salvatore J Sr Guccione SrCEOSell9,114$24.19$220,467.66View SEC Filing  
7/2/2015Satish SrinivasanCOOSell1,921$24.19$46,468.99View SEC Filing  
6/8/2015Raymond BartoneSVPSell5,000$24.44$122,200.00View SEC Filing  
6/3/2015Frank DebenedittisVPSell4,000$24.41$97,640.00View SEC Filing  
5/27/2015Charles John AlaimoSVPSell2,000$23.19$46,380.00View SEC Filing  
5/12/2015William N BrittonDirectorSell13,000$21.31$277,030.00View SEC Filing  
3/4/2015Douglas A RothCFOSell5,000$20.99$104,950.00View SEC Filing  
3/4/2015Natasha GiordanoDirectorSell2,164$20.92$45,270.88View SEC Filing  
2/12/2015Douglas A RothCFOSell6,000$19.91$119,460.00View SEC Filing  
2/10/2015Charles John AlaimoSVPSell2,000$20.15$40,300.00View SEC Filing  
12/9/2014Frank DebenedittisVPSell3,000$21.25$63,750.00View SEC Filing  
12/5/2014Douglas A RothCFOSell7,000$22.07$154,490.00View SEC Filing  
12/3/2014Terry KippleyVPSell1,950$21.35$41,632.50View SEC Filing  
12/2/2014Terry KippleyVPSell1,797$21.45$38,545.65View SEC Filing  
12/1/2014Satish SrinivasanCOOSell1,430$21.00$30,030.00View SEC Filing  
11/11/2014Charles John AlaimoSVPSell2,250$21.22$47,745.00View SEC Filing  
9/9/2014Douglas A RothCFOSell6,000$21.57$129,420.00View SEC Filing  
9/9/2014Natasha GiordanoDirectorSell1,453$21.94$31,878.82View SEC Filing  
9/9/2014Raymond BartoneSVPSell3,000$21.49$64,470.00View SEC Filing  
9/9/2014Steven RogersVPSell8,335$21.50$179,202.50View SEC Filing  
9/2/2014Albert L EilenderChairmanSell7,144$19.14$136,736.16View SEC Filing  
8/29/2014Hans C NoetzliDirectorSell2,000$18.85$37,700.00View SEC Filing  
8/15/2014Hans C NoetzliDirectorSell2,000$18.63$37,260.00View SEC Filing  
8/4/2014Albert L EilenderChairmanSell4,195$16.71$70,098.45View SEC Filing  
8/1/2014Hans C NoetzliDirectorSell2,000$16.67$33,340.00View SEC Filing  
7/25/2014Albert L EilenderChairmanSell2,450$17.63$43,193.50View SEC Filing  
7/3/2014Hans C NoetzliDirectorSell2,000$17.86$35,720.00View SEC Filing  
7/2/2014Albert L EilenderChairmanSell1,750$18.05$31,587.50View SEC Filing  
6/6/2014Charles John AlaimoSVPSell2,000$17.51$35,020.00View SEC Filing  
6/6/2014Natasha GiordanoDirectorSell1,160$17.28$20,044.80View SEC Filing  
6/6/2014Steven RogersVPSell2,333$17.58$41,014.14View SEC Filing  
6/4/2014Frank DebenedittisVPSell30,000$17.09$512,700.00View SEC Filing  
6/4/2014Nicolas I ShackleyInsiderSell1,000$17.29$17,290.00View SEC Filing  
6/2/2014Douglas A RothCFOSell6,500$17.10$111,150.00View SEC Filing  
6/2/2014Natasha GiordanoDirectorSell1,149$17.43$20,027.07View SEC Filing  
5/23/2014Natasha GiordanoDirectorSell1,128$17.91$20,202.48View SEC Filing  
5/21/2014Natasha GiordanoDirectorSell1,110$17.81$19,769.10View SEC Filing  
3/10/2014Terry KippleyVPSell3,817$19.17$73,171.89View SEC Filing  
2/14/2014Roger Weaving, Jr.SVPSell6,000$18.96$113,760.00View SEC Filing  
11/12/2013Roger Weaving, Jr.SVPSell14,605$19.03$277,933.15View SEC Filing  
9/6/2013Raymond BartoneSVPSell19,000$14.84$281,960.00View SEC Filing  
6/7/2013Roger Weaving JrVPSell4,420$13.02$57,548.40View SEC Filing  
6/6/2013Guillaume Saint-ClairVPSell15,332$13.01$199,469.32View SEC Filing  
6/4/2013Douglas A RothCFOSell30,000$13.31$399,300.00View SEC Filing  
6/4/2013Eis Jan VanDirectorSell9,000$13.39$120,510.00View SEC Filing  
5/24/2013Ronald GoldCOOSell25,000$11.71$292,750.00View SEC Filing  
5/22/2013Frank DebenedittisVPSell8,300$11.86$98,438.00View SEC Filing  
5/21/2013Frank DebenedittisVPSell7,867$12.00$94,404.00View SEC Filing  
5/17/2013Douglas A RothCFOSell20,200$11.31$228,462.00View SEC Filing  
5/17/2013Guillaume Saint-ClairVPSell2,250$11.15$25,087.50View SEC Filing  
5/15/2013Ronald GoldCOOSell55,000$11.23$617,650.00View SEC Filing  
5/14/2013David B RosenVPSell40,000$11.05$442,000.00View SEC Filing  
5/14/2013Roger Weaving JrSVPSell5,600$11.09$62,104.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aceto Corporation (NASDAQ ACET)

Source:
DateHeadline
Aceto Corporation (ACET) Receives Consensus Rating of "Hold" from BrokeragesAceto Corporation (ACET) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 14 at 1:50 AM
Zacks Investment Research Lowers Aceto Corporation (ACET) to Strong SellZacks Investment Research Lowers Aceto Corporation (ACET) to Strong Sell
www.americanbankingnews.com - November 9 at 4:56 PM
Q3 2018 EPS Estimates for Aceto Corporation (ACET) Cut by First AnalysisQ3 2018 EPS Estimates for Aceto Corporation (ACET) Cut by First Analysis
www.americanbankingnews.com - November 9 at 1:50 PM
Relative Strength Alert For AcetoRelative Strength Alert For Aceto
www.thestreet.com - November 8 at 10:20 PM
Analysts Offer Predictions for Aceto Corporations Q2 2018 Earnings (ACET)Analysts Offer Predictions for Aceto Corporation's Q2 2018 Earnings (ACET)
www.americanbankingnews.com - November 8 at 6:24 PM
ETFs with exposure to Aceto Corp. : November 7, 2017ETFs with exposure to Aceto Corp. : November 7, 2017
finance.yahoo.com - November 7 at 4:52 PM
Edited Transcript of ACET earnings conference call or presentation 3-Nov-17 1:00pm GMTEdited Transcript of ACET earnings conference call or presentation 3-Nov-17 1:00pm GMT
finance.yahoo.com - November 4 at 1:23 AM
Aceto Corporation 2018 Q1 - Results - Earnings Call SlidesAceto Corporation 2018 Q1 - Results - Earnings Call Slides
seekingalpha.com - November 3 at 3:16 PM
Aceto posts 1Q profitAceto posts 1Q profit
finance.yahoo.com - November 3 at 10:20 AM
Aceto Corporation to Host Earnings CallAceto Corporation to Host Earnings Call
finance.yahoo.com - November 3 at 10:20 AM
Aceto Corporation (ACET) Posts  Earnings Results, Beats Estimates By $0.01 EPSAceto Corporation (ACET) Posts Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - November 2 at 9:28 PM
Aceto Corporation (ACET) Issues FY18 Earnings GuidanceAceto Corporation (ACET) Issues FY18 Earnings Guidance
www.americanbankingnews.com - November 2 at 9:28 PM
BRIEF-Aceto reports fiscal 2018 first quarter resultsBRIEF-Aceto reports fiscal 2018 first quarter results
www.reuters.com - November 2 at 8:30 PM
Aceto Corp. Reveals 29% Rise In Q1 EarningsAceto Corp. Reveals 29% Rise In Q1 Earnings
www.rttnews.com - November 2 at 8:30 PM
ACETO Reports Fiscal 2018 First Quarter ResultsACETO Reports Fiscal 2018 First Quarter Results
finance.yahoo.com - November 2 at 8:30 PM
Will Aceto Corporation’s (ACET) Earnings Grow Over The Next Year?Will Aceto Corporation’s (ACET) Earnings Grow Over The Next Year?
finance.yahoo.com - November 2 at 3:27 PM
Aceto Corporation (ACET) Lifted to Hold at Zacks Investment ResearchAceto Corporation (ACET) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - October 30 at 4:36 PM
Aceto Corporation (ACET) Earns Buy Rating from Canaccord GenuityAceto Corporation (ACET) Earns Buy Rating from Canaccord Genuity
www.americanbankingnews.com - October 30 at 6:16 AM
Aceto Corporation (ACET) to Release Earnings on ThursdayAceto Corporation (ACET) to Release Earnings on Thursday
www.americanbankingnews.com - October 26 at 3:48 AM
ETFs with exposure to Aceto Corp. : October 25, 2017ETFs with exposure to Aceto Corp. : October 25, 2017
finance.yahoo.com - October 25 at 4:15 PM
ACETO Subsidiary, Rising Pharmaceuticals, Launches Sertraline Oral Solution, 20mg/mlACETO Subsidiary, Rising Pharmaceuticals, Launches Sertraline Oral Solution, 20mg/ml
www.nasdaq.com - October 24 at 3:24 PM
ACETO Subsidiary, Rising Pharmaceuticals, Launches Sertraline Oral Solution, 20mg/mlACETO Subsidiary, Rising Pharmaceuticals, Launches Sertraline Oral Solution, 20mg/ml
finance.yahoo.com - October 24 at 3:24 PM
Head-To-Head Contrast: Aceto Corporation (ACET) & Its PeersHead-To-Head Contrast: Aceto Corporation (ACET) & Its Peers
www.americanbankingnews.com - October 22 at 2:28 AM
ACETO Corporation Schedules First Quarter Fiscal 2018 Financial Results News Release and Conference CallACETO Corporation Schedules First Quarter Fiscal 2018 Financial Results News Release and Conference Call
finance.yahoo.com - October 20 at 3:34 PM
Financial Analysis: Aceto Corporation (ACET) and Its PeersFinancial Analysis: Aceto Corporation (ACET) and Its Peers
www.americanbankingnews.com - October 13 at 8:30 PM
ETFs with exposure to Aceto Corp. : October 3, 2017ETFs with exposure to Aceto Corp. : October 3, 2017
finance.yahoo.com - October 3 at 3:09 PM
How To YieldBoost ACET To 19.4% Using OptionsHow To YieldBoost ACET To 19.4% Using Options
www.thestreet.com - October 2 at 8:17 PM
BRIEF-ACETO appoints William Kennally, III president and CEOBRIEF-ACETO appoints William Kennally, III president and CEO
www.reuters.com - September 28 at 8:41 PM
Aceto Becomes OversoldAceto Becomes Oversold
www.thestreet.com - September 28 at 8:41 PM
ACETO Appoints William C. Kennally, III President and CEOACETO Appoints William C. Kennally, III President and CEO
www.nasdaq.com - September 28 at 8:41 PM
Head-To-Head Survey: Aceto Corporation (ACET) vs. The CompetitionHead-To-Head Survey: Aceto Corporation (ACET) vs. The Competition
www.americanbankingnews.com - September 26 at 4:28 PM
Aceto Corporation (ACET) Receives Average Recommendation of "Hold" from BrokeragesAceto Corporation (ACET) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - September 25 at 2:38 AM
Head to Head Comparison: Immune Pharmaceuticals (IMNP) versus Aceto Corporation (ACET)Head to Head Comparison: Immune Pharmaceuticals (IMNP) versus Aceto Corporation (ACET)
www.americanbankingnews.com - September 19 at 8:10 PM
Financial Review: Neos Therapeutics (NEOS) versus Aceto Corporation (ACET)Financial Review: Neos Therapeutics (NEOS) versus Aceto Corporation (ACET)
www.americanbankingnews.com - September 14 at 10:33 AM
Aceto (ACET) Presents At Morgan Stanley 15th Annual Global Healthcare Conference - SlideshowAceto (ACET) Presents At Morgan Stanley 15th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - September 14 at 1:42 AM
Aceto Corporation (ACET) SVP Sells $20,680.00 in StockAceto Corporation (ACET) SVP Sells $20,680.00 in Stock
www.americanbankingnews.com - September 8 at 9:02 PM
Earnings Review and Free Research Report: Braskem’s Net Income Soared 316%Earnings Review and Free Research Report: Braskem’s Net Income Soared 316%
finance.yahoo.com - September 7 at 3:17 PM
Insider Selling: Aceto Corporation (ACET) SVP Sells 2,050 Shares of StockInsider Selling: Aceto Corporation (ACET) SVP Sells 2,050 Shares of Stock
www.americanbankingnews.com - September 6 at 9:38 PM
Aceto Corporation (ACET) Chairman Albert L. Eilender Sells 9,530 SharesAceto Corporation (ACET) Chairman Albert L. Eilender Sells 9,530 Shares
www.americanbankingnews.com - September 6 at 9:16 PM
Insider Selling: Aceto Corporation (ACET) Insider Sells 9,850 Shares of StockInsider Selling: Aceto Corporation (ACET) Insider Sells 9,850 Shares of Stock
www.americanbankingnews.com - September 6 at 8:52 PM
Aceto Corporation (ACET) COO Walter J. Kaczmarek III Sells 2,635 SharesAceto Corporation (ACET) COO Walter J. Kaczmarek III Sells 2,635 Shares
www.americanbankingnews.com - September 5 at 8:52 PM
ACETO to Present at the Morgan Stanley 15th Annual Global Healthcare ConferenceACETO to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
finance.yahoo.com - September 5 at 3:32 PM
ETFs with exposure to Aceto Corp. : September 1, 2017ETFs with exposure to Aceto Corp. : September 1, 2017
finance.yahoo.com - September 1 at 8:52 PM
Weakness Seen in Aceto Corporation (ACET) Estimates: Should You Stay Away?Weakness Seen in Aceto Corporation (ACET) Estimates: Should You Stay Away?
finance.yahoo.com - August 31 at 3:18 PM
Q3 2018 EPS Estimates for Aceto Corporation Cut by Analyst (ACET)Q3 2018 EPS Estimates for Aceto Corporation Cut by Analyst (ACET)
www.americanbankingnews.com - August 31 at 11:40 AM
Aceto Corporation (ACET) Receives Average Rating of "Hold" from BrokeragesAceto Corporation (ACET) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - August 31 at 2:46 AM
Q1 2018 EPS Estimates for Aceto Corporation Reduced by Analyst (ACET)Q1 2018 EPS Estimates for Aceto Corporation Reduced by Analyst (ACET)
www.americanbankingnews.com - August 30 at 8:44 AM
First Analysis Comments on Aceto Corporations Q1 2018 Earnings (ACET)First Analysis Comments on Aceto Corporation's Q1 2018 Earnings (ACET)
www.americanbankingnews.com - August 30 at 8:44 AM
Aceto Corp. :ACET-US: Earnings Analysis: Q4, 2017 By the Numbers : August 29, 2017Aceto Corp. :ACET-US: Earnings Analysis: Q4, 2017 By the Numbers : August 29, 2017
finance.yahoo.com - August 29 at 3:42 PM
Equities Analysts Issue Forecasts for Aceto Corporations Q3 2018 Earnings (ACET)Equities Analysts Issue Forecasts for Aceto Corporation's Q3 2018 Earnings (ACET)
www.americanbankingnews.com - August 29 at 11:44 AM

Social Media

Financials

Chart

Aceto Corporation (NASDAQ ACET) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.